Global Opioids Market Research Report 2017 - Top Manufacturers Pfizer Inc, Purdue Pharma, Sanofi, Boehringer Ingelheim, Actavis Plc

Researchmoz added Most up-to-date research on "Global Opioids Market Research Report 2017" to its huge collection of research reports.

In this report, the global Opioids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Opioids in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Opioids market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pfizer Inc
Purdue Pharma
Boehringer Ingelheim
Janssen Pharmaceuticals
Actavis Plc
Sanofi
Sun Pharmaceutical Industries Ltd
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc
Egalet
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Morphine
Codeine
Methadone
Meperidine
Fentanyl
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Opioids for each application, including
Anesthesia
Cough Suppressant
Diarrhea suppressant

If you have any special requirements, please let us know and we will offer you the report as you want.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1197751

Table of Contents

Global Opioids Market Research Report 2017
1 Opioids Market Overview1.1 Product Overview and Scope of Opioids
1.2 Opioids Segment by Type (Product Category)
1.2.1 Global Opioids Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Opioids Production Market Share by Type (Product Category) in 2016
1.2.3 Morphine
1.2.4 Codeine
1.2.5 Methadone
1.2.6 Meperidine
1.2.7 Fentanyl
1.3 Global Opioids Segment by Application
1.3.1 Opioids Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Anesthesia
1.3.3 Cough Suppressant
1.3.4 Diarrhea suppressant
1.4 Global Opioids Market by Region (2012-2022)
1.4.1 Global Opioids Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Opioids (2012-2022)
1.5.1 Global Opioids Revenue Status and Outlook (2012-2022)
1.5.2 Global Opioids Capacity, Production Status and Outlook (2012-2022)

2 Global Opioids Market Competition by Manufacturers
2.1 Global Opioids Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Opioids Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Opioids Production and Share by Manufacturers (2012-2017)
2.2 Global Opioids Revenue and Share by Manufacturers (2012-2017)
2.3 Global Opioids Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Opioids Manufacturing Base Distribution, Sales Area and Product Type
2.5 Opioids Market Competitive Situation and Trends
2.5.1 Opioids Market Concentration Rate
2.5.2 Opioids Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Opioids Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Opioids Capacity and Market Share by Region (2012-2017)
3.2 Global Opioids Production and Market Share by Region (2012-2017)
3.3 Global Opioids Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Opioids Supply (Production), Consumption, Export, Import by Region (2012-2017)4.1 Global Opioids Consumption by Region (2012-2017)
4.2 North America Opioids Production, Consumption, Export, Import (2012-2017)
4.3 Europe Opioids Production, Consumption, Export, Import (2012-2017)
4.4 China Opioids Production, Consumption, Export, Import (2012-2017)
4.5 Japan Opioids Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Opioids Production, Consumption, Export, Import (2012-2017)
4.7 India Opioids Production, Consumption, Export, Import (2012-2017)

5 Global Opioids Production, Revenue (Value), Price Trend by Type
5.1 Global Opioids Production and Market Share by Type (2012-2017)
5.2 Global Opioids Revenue and Market Share by Type (2012-2017)
5.3 Global Opioids Price by Type (2012-2017)
5.4 Global Opioids Production Growth by Type (2012-2017)

6 Global Opioids Market Analysis by Application
6.1 Global Opioids Consumption and Market Share by Application (2012-2017)
6.2 Global Opioids Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Opioids Manufacturers Profiles/Analysis
7.1 Pfizer Inc
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Opioids Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer Inc Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Purdue Pharma
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Opioids Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Purdue Pharma Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Opioids Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Boehringer Ingelheim Opioids Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1197751

The US Chronic Pain Market - Focus on Opioids (2014-2019) Key Trends, Size, Growth, Shares And Forecast Research Report

Researchmoz added Most up-to-date research on "The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019)" to its huge collection of research reports.

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Segment Coverage

- Oxycodone
- Hydrocodone
- Morphine
- Hydromorphone
- Fentanyl
- Dihydrocodeine
- Methadone

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=240177

Company Coverage

- Zogenix Inc.
- Egalet Corporation
- NektarTheropeutics

Executive Summary

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=240177